"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
DOSAGE AND ADMINISTRATION
Apply a thin film of DIPROLENE AF (betamethasone) Cream 0.05% to the affected skin areas once or twice daily. Treatment with DIPROLENE AF (betamethasone) Cream 0.05% should be limited to 45 g per week.
DIPROLENE AF (betamethasone) Cream 0.05% is not to be used with occlusive dressings.
DIPROLENE AF (betamethasone) Cream 0.05% is supplied in 15-g (NDC 0085-0517-01) and 50-g (NDC 0085-0517-04) tubes; boxes of one.
Store at 25°C (77°F); excursions permitted to 15 - 30°C (59 – 86°F) [see USP Controlled Room Temperature].
Schering Corporation, Kenilworth, NJ 07033, USA. Rev. 10/05. FDA Rev date: 8/28/2006
Last reviewed on RxList: 10/14/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Diprolene AF Information
Diprolene AF - User Reviews
Diprolene AF User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.